Brief: Genezen To Acquire Uniqure's Commercial Gene Therapy Manufacturing Operations In Lexington, Ma
01/07/2024 12:07
July 1 (Reuters) - Uniqure NV UQ1.F :
* GENEZEN TO ACQUIRE UNIQURE'S COMMERCIAL GENE THERAPY
MANUFACTURING OPERATIONS IN LEXINGTON, MA
* TRANSACTION FUNDED IN PART BY ADDITIONAL GROWTH EQUITY
FROM
AMPERSAND CAPITAL
Source text for Eikon: ID:nPn7YZlV4a
Further company coverage: UQ1.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal